Abstract:Introduction: Non-typhoidal Salmonella (NTS) generally causes self-limiting gastroenteritis. However, older adults (≥65 years) can experience more severe outcomes from NTS infection. We have previously shown that a live attenuated S . Typhimurium vaccine, CVD 1926 (I77 Δ guaBA Δ clpP Δ pipA Δ htrA ), was immunogenic in adult but not aged mice. Here we describe modification of CVD 1926 through deletion of steD , a Salmonella effector responsible for host immune escape, which we hypothesized would increase immunogenicity in aged mice. Methods: Mel Juso and/or mutuDC cells were infected with S . Typhimurium I77, CVD 1926, and their respective steD mutants, and the MHC-II levels were evaluated. Aged (18-month-old) C57BL/6 mice received two doses of PBS, CVD 1926, or CVD 1926 Δ steD perorally (10 9 CFU) and the number of FliC-specific CD4 + T cells were determined. Lastly, aged C57BL/6 mice received three doses of PBS, CVD 1926, or CVD 1926 Δ steD perorally (10 9 CFU) and then were challenged perorally with wild-type S . Typhimurium SL1344 (10 8 CFU). These animals were also evaluated for antibody responses. Results: MHC-II induction was higher in cells treated with steD mutants, compared to their respective parental strains. Compared to PBS-vaccinated mice, CVD 1926 Δ steD elicited significantly more FliC-specific CD4 + T cells in the Peyer's Patches. There were no significant differences in FliC-specific CD4 + T cells in the Peyer's patches or spleen of CVD 1926- versus PBS-immunized mice. CVD 1926 and CVD 1926 Δ steD induced similar serum and fecal anti-core and O polysaccharide antibody titers after three doses. After two immunizations, the proportion of seroconverters for CVD 1926 Δ steD was 83% (10/12) compared to 42% (5/12) for CVD 1926. Compared to PBS-immunized mice, mice immunized with CVD 1926 Δ steD had significantly lower S . Typhimurium counts in the spleen, cecum, and small intestine upon challenge. In contrast, there were no differences in bacterial loads in the tissues of PBS-vaccinated and CVD 1926-immunized animals. Conclusion: These data suggest that the steD deletion enhanced the immunogenicity of our live attenuated S . Typhimurium vaccine. Deletion of immune evasion genes could be a potential strategy to improve the immunogenicity of live attenuated vaccines in older adults.

Effect of Deletion of Gene Cluster Involved in Synthesis of Enterobacterial Common Antigen on Virulence and Immunogenicity of Live Attenuated Salmonella Vaccine when Delivering Heterologous Streptococcus Pneumoniae Antigen PspA

Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.

Reversible Synthesis of Colanic Acid and O-antigen Polysaccharides in Salmonella Typhimurium Enhances Induction of Cross-Immune Responses and Provides Protection Against Heterologous Salmonella Challenge.

Physiology, Pathogenicity and Immunogenicity of Live, Attenuated Salmonella Enterica Serovar Enteritidis Mutants in Chicks

Deletion of an immune evasion gene, steD, from a live Salmonella enterica serovar Typhimurium vaccine improves vaccine responses in aged mice

The peptidoglycan-associated lipoprotein gene mutant elicits robust immunological defense in mice against Salmonella enteritidis

Immunogenicity And Cross-Protective Efficacy Induced By Outer Membrane Proteins From Salmonella Typhimurium Mutants With Truncated Lps In Mice

Immunogenicity and cross-protective efficacy induced by delayed attenuated Salmonella with regulated length of lipopolysaccharide in mice

Regulated Delayed Shigella flexneri 2a O-antigen Synthesis in Live Recombinant Salmonella enterica Serovar Typhimurium Induces Comparable Levels of Protective Immune Responses with Constitutive Antigen Synthesis System.

Regulated Delayed Expression of Rfc Enhances the Immunogenicity and Protective Efficacy of a Heterologous Antigen Delivered by Live Attenuated Salmonella Enterica Vaccines.

A Biologically Conjugated Polysaccharide Vaccine Delivered by Attenuated Salmonella Typhimurium Provides Protection Against Challenge of Avian Pathogenic Escherichia Coli O1 Infection

[Characterization of Attenuated Salmonella C500 Strain with a Delta Asd Mutant and Use As an Asd+ Balanced-Lethal Host-Vector System].

Construction and Characterization of △ssek2 Mutant Strain of Salmonella Typhimurium SL1344

Palmitoylation State Impacts Induction of Innate and Acquired Immunity by the Salmonella Enterica Serovar Typhimurium Msbb Mutant

Generation and evaluation of Salmonella enterica serovar Choleraesuis mutant strains as a potential live-attenuated vaccine

Recombinant attenuated Salmonella Typhimurium with heterologous expression of the Salmonella Choleraesuis O-polysaccharide: high immunogenicity and protection

Construction and characterization of secreted effector K1 gene deleted mutant of Salmonella typhimurium SL1344 strain

Effective mucosal live attenuated Salmonella vaccine by deleting phosphotransferase system component genes ptsI and crr

Construction and Characterization of△ crp△ asd Mutant Host- Vector Balanced Lethal System of Salmonella choleraesuis C500 Strain

Cytolysin A-mediated protein exportation efficiency and its role in enhancing the fitness of live recombinant Salmonella Typhi vaccine strain

Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA